Greg Licholai is a biopharm executive, Harvard and Yale faculty, Forbes contributor, McKinsey consultant with drug development, digital, and rare disease expertise. He has a proven track record of growing and leading multiple functional areas in healthcare and service companies, namely Quintiles, Medtronic, and ICON.
Speaking In
1:00 PM - 2:00 PM
Monday, June 5